US 10258630
Vaginal inserted estradiol pharmaceutical compositions and methods
granted A61KA61K2300/00A61K31/565
Quick answer
US patent 10258630 (Vaginal inserted estradiol pharmaceutical compositions and methods) held by Compass Therapeutics LLC expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2300/00, A61K31/565, A61K31/57, A61K47/14